CUSIP No. G6674U 108	  	13G	  	Page 1 of 7 Pages	
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO
RULE 13d-2
(Amendment No. 2)*

NovoCure Limited
(Name of Issuer)
Ordinary Shares, no par value
(Title of Class of Securities)
G6674U 108
(CUSIP Number)
December 31, 2016
(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
☐ Rule 13d-1(b)
☐ Rule 13d-1(c)
☒ Rule 13d-1(d)
 
*	The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.	
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 
 
Page 1 of 7 Pages

					
CUSIP No. G6674U 108	 	13G	 	Page 2 of 7 Pages	

  1 	 	NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
 
William F. Doyle	
  2	 	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a)  ☐        (b)  ☐
 	
  3	 	SEC USE ONLY
 	
  4	 	CITIZENSHIP OR PLACE OF ORGANIZATION
 
United States	
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH	  	5 	  	SOLE VOTING POWER
 
19,870,843(1) (see Item 4)	
	  	6	  	SHARED VOTING POWER
 
0	
	  	7	  	SOLE DISPOSITIVE POWER
 
19,870,843(1) (see Item 4)	
	  	8	  	SHARED DISPOSITIVE POWER
 
0	
  9	 	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
19,870,843(1) (see Item 4)	
10	 	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)  ☐
 	
11	 	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 
22.7%(1) (see Item 4)	
12	 	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
IN	
 
(1)	William F. Doyle and WFD Ventures Fund II, L.P. are filing this Amendment in order to amend and restate the incorrect shares beneficially owned and percentages.	
 
Page 2 of 7 Pages

					
CUSIP No. G6674U 108	 	13G	 	Page 3 of 7 Pages	

  1 	 	NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
 
WFD Ventures Fund II, L.P.	
  2	 	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a)  ☐        (b)  ☐
 	
  3	 	SEC USE ONLY
 	
  4	 	CITIZENSHIP OR PLACE OF ORGANIZATION
 
Cayman Islands	
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH	  	5 	  	SOLE VOTING POWER
 
19,775,767(1) (see Item 4)	
	  	6	  	SHARED VOTING POWER
 
0	
	  	7	  	SOLE DISPOSITIVE POWER
 
19,775,767(1) (see Item 4)	
	  	8	  	SHARED DISPOSITIVE POWER
 
0	
  9	 	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
19,775,767(1) (see Item 4)	
10	 	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)  ☐
 	
11	 	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 
22.5%(1) (see Item 4)	
12	 	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
FI	
 
(1)	William F. Doyle and WFD Ventures Fund II, L.P. are filing this Amendment in order to amend and restate the incorrect shares beneficially owned and percentages.	
 
Page 3 of 7 Pages

					
CUSIP No. G6674U 108	  	13G	  	Page 4 of 7 Pages	
 
Schedule 13G
 
Item 1(a).	Name of Issuer :	
NovoCure Limited
 
Item 1(b).	Address of Issuer’s Principal Executive Offices :	
Le Masurier House, La Rue Le Masurier, St. Helier, Jersey JE2 4YE
 
Item 2(a).	Name of Persons Filing :	
This statement is filed by:
 
 	•	 	William F. Doyle	
 
 	•	 	WFD Ventures Fund II, L.P.	
This Amendment No. 2 to the Schedule 13G, filed on February 12, 2016 (as amended by Amendment No. 1 there to filed on February 14, 2017), is being filed on behalf of William F. Doyle and WFD Ventures Fund II, L.P.
William F. Doyle and WFD Ventures Fund II, L.P. entered into a Joint Filing Agreement, a copy of which was filed on February 12, 2016 with the Schedule 13G as Exhibit 99.1, pursuant to which they have agreed to file this Schedule 13G/A jointly in accordance with the provisions of Rule 13d-1(k) of the Act.
 
Item 2(b).	Address of Principal Business Office or, if None, Residence :	
For Mr. Doyle and WFD Ventures Fund II, L.P.:
c/o Novocure Inc., 20 Valley Stream Pkwy, Suite 300, Malvern, PA 19355
 
Item 2(c).	Citizenship :	
For WFD Ventures Fund II, L.P., Grand Cayman. Mr. Doyle is a citizen of the United States of America.
 
Item 2(d).	Title of Class of Securities :	
Ordinary Shares, no par value
 
Item 2(e).	CUSIP Number :	
G6674U 108
 
Item 3.	Not applicable.	
 
Page 4 of 7 Pages

					
CUSIP No. G6674U 108	  	13G	  	Page 5 of 7 Pages	
 
Item 4.	Ownership .	
The information required by this item with respect to each Reporting Person is set forth in Rows 5 through 9 and 11 of the cover page to this Schedule 13G.
The percent of class represented by the amount beneficially owned by each Reporting Person is based on 87,072,949 Ordinary Shares outstanding on February 16, 2017 as indicated to each Reporting Person by the Issuer.
The Ordinary Shares to which Mr. Doyle has sole voting or dispositive power consist of (i) 84,699 Ordinary Shares held by Mr. Doyle; (ii) 10,377 Ordinary Shares underlying warrants exercisable that are held by Mr. Doyle; and (iii) 19,775,767 Ordinary Shares held by WFD Ventures Fund II, L.P.
The Ordinary Shares to which WFD Ventures Fund II, L.P. has sole voting or dispositive power consist of (i) 19,775,767 Ordinary Shares held by WFD Ventures Fund II, L.P.
Mr. Doyle is a managing director of WFD Ventures LLC, the sole member of WFD-GP II LLC, which is the general partner of WFD Ventures Fund II, L.P. Mr. Doyle possesses sole voting and investment power over shares owned by WFD Ventures Fund II, L.P. (subject to certain rights of the advisory board of WFD Ventures Fund II, L.P. to approve sales of any of the shares owned by WFD Ventures Fund II, L.P.).
 
Item 5.	Ownership of Five Percent or Less of a Class .	
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following  ☐.
 
Item 6.	Ownership of More than Five Percent on Behalf of Another Person .	
Not applicable.
 
Item 7.	Identification and Classification of the Subsidiary which Acquired the Security Being Reported on By the Parent Holding Company or Control Person .	
Not applicable.
 
Item 8.	Identification and Classification of Members of the Group .	
Not applicable.
 
Item 9.	Notice of Dissolution of Group .	
Not applicable.
 
Page 5 of 7 Pages

					
CUSIP No. G6674U 108	  	13G	  	Page 6 of 7 Pages	
 
Item 10.	Certification .	
Not applicable.
 
Page 6 of 7 Pages

					
CUSIP No. G6674U 108	  	13G	  	Page 7 of 7 Pages	
 
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: March 2, 2017

WILLIAM F. DOYLE	
		
By:	 	/s/ William F. Doyle	
Name: William F. Doyle	

WFD VENTURES FUND II, L.P.	
		
By:	 	WFD-GP II LLC, its General Partner	
		
By:	 	WFD Ventures LLC, its Sole Member	
	
/s/ William F. Doyle	
Name: William F. Doyle	
Title: Managing Director	
 
Page 7 of 7 Pages